<DOC>
	<DOCNO>NCT00647075</DOCNO>
	<brief_summary>The purpose study assess effect dietary supplement , traditional Asian mushroom Yunzhi , adjuvant treatment patient breast cancer .</brief_summary>
	<brief_title>Yunzhi Dietary Supplement Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Women diagnosis breast cancer 2 . Undergoing adjuvant/neoadjuvant chemotherapy either FEC , FAC , TAC , EC + docetaxel combination . 3 . â‰¥ 18 year age 4 . Performance status : 02 5 . Ability provide write informed consent 1 . Any prior history yunzhi use 2 . Use herbal remedy study duration 3 . Significant cardiac , pulmonary , renal , hepatic , gastrointestinal , CNS , psychiatric disease illicit substance use/abuse opinion investigator would make participant poor candidate study participation 4 . Pregnancy ( woman childbearing potential , negative pregnancy test , urine serum , require within 14 day prior randomization ) 5 . Systemic use progestin , androgen steroid ( dexamethasone allow use antiemetic therapy )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>undergo</keyword>
	<keyword>adjuvant/neoadjuvant chemotherapy</keyword>
	<keyword>symptomatic therapy</keyword>
</DOC>